线粒体分裂
粒体自噬
生物
线粒体
线粒体融合
DNM1L型
生物信息学
表观遗传学
线粒体DNA
医学
计算生物学
神经科学
遗传学
基因
自噬
细胞凋亡
作者
Parmar Keshri Nandan,Anica Tholath Job,Ramasamy Tamizhselvi
出处
期刊:Current Drug Targets
[Bentham Science]
日期:2024-09-06
卷期号:25
标识
DOI:10.2174/0113894501304751240819111831
摘要
Abstract: In recent years, mitochondria have gained significant interest in the field of biomedical research due to their impact on aging, human health, and other advanced findings in metabolic functions. The latest finding shows that metabolic interventions are a leading cause of several diseases, which has sparked interest in finding new therapeutic treatments. Apart from this, the unique inheritance of genetic material from mother to offspring can help scientists find ways to prevent mitochondrial inherited diseases. Additionally, the anti-aging benefits of controlling mitochondrial functions are also being researched. The present study aims to provide a cohesive overview of the latest findings in mitochondrial research, focusing on the role of DRP1 (Dynamin- related protein 1), a member of the GTPase family, in mediating mitochondrial fission. The first section of this paper provides a concise explanation of how DRP1 controls processes such as mitophagy and mitochondrial fission. Subsequently, the paper delves into the topic of inflammation, discussing the current findings regarding the inflammatory response mediated by DRP1. Finally, the role of mitochondrial fission mediated by DRP1 in cancer is examined, reviewing ongoing research on various types of cancer and their recurrence. Moreover, this review also covers the epigenetic regulation of mitochondrial fission. The studies were selected, and evaluated, and the information was collected to present an overview of the key findings. By exploring various aspects of research and potential links, we hope to contribute to a deeper understanding of the intricate relationship between the fields of cancer research and inflammation studies with respect to mitochondrial- based research.
科研通智能强力驱动
Strongly Powered by AbleSci AI